)
)
Exscientia Investor Relations Material
Latest events
Q1 2024
Exscientia
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Exscientia plc
Access all reports
Exscientia plc is a pharmatech company leveraging artificial intelligence (AI) in the discovery, design, and development of drugs. The company employs a patient-first AI approach across various stages of drug development, including precision target identification, design, experimentation, and medicine optimization. It aims to accelerate the process of bringing new, effective treatments to patients with a focus on precision oncology and a broader range of therapeutic areas through partnered pipelines. The company is headquartered in Oxford, United Kingdom, and its shares are listed on the Nasdaq.
Key slides for Exscientia plc
Q1 2024
Exscientia plc
Corporate Presentation
Exscientia plc
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
EXAI
Country
🇺🇸 United States